Supply of Aseptically Prepared Dose Banded Medicines
Estimated value
—
Awarded value
—
Suppliers
8
Lots
28
Published
13 Jul 2022
Description
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
Scope
- Reference
- SF051571
- Commercial tool
- Standalone contract
- Contract dates
Framework can be extended for up to a period of 24 months at HealthTrust Europe`s discretion.
- Main category
- goods
- CPV classifications
- 33600000336920008514900033680000
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Quality | 60% | quality | — |
| Price | 40% | cost | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 3 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 28 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1.1 | BORTEZOMIB | £100.0m | cancelled |
| 1.2 | CARBOPLATIN | £100.0m | cancelled |
| 1.3 | CETUXIMAB | £100.0m | cancelled |
| 1.4 | CISPLATIN | £100.0m | cancelled |
| 1.5 | CYCLOPHOSPHAMIDE | £100.0m | cancelled |
Award 1· 1 supplier
Awarded —
Award 2· 3 suppliers
Awarded —
Award 3· 4 suppliers
Awarded —
Total lots
28
Awarded
2
Estimated total
£3.5bn
Awarded total
—
BORTEZOMIB
Start
—
End
—
Estimated
£100.0m
CPV
CARBOPLATIN
Start
—
End
—
Estimated
£100.0m
CPV
CETUXIMAB
Start
—
End
—
Estimated
£100.0m
CPV
CISPLATIN
Start
—
End
—
Estimated
£100.0m
CPV
CYCLOPHOSPHAMIDE
Start
—
End
—
Estimated
£100.0m
CPV
CYTARABINE
Start
—
End
—
Estimated
£100.0m
CPV
DESFERRIOXAMINE
Start
—
End
—
Estimated
£100.0m
CPV
DOCETAXEL
Start
—
End
—
Estimated
£100.0m
CPV
DOXORUBICIN
Start
—
End
—
Estimated
£100.0m
CPV
EPIRUBICIN
Start
—
End
—
Estimated
£100.0m
CPV
FLUOROURACIL
Start
—
End
—
Estimated
£100.0m
CPV
GANCICLOVIR
Start
—
End
—
Estimated
£100.0m
CPV
GEMCITABINE
Start
—
End
—
Estimated
£100.0m
CPV
INFLIXIMAB
Start
—
End
—
Estimated
£100.0m
CPV
IRINOTECAN
Start
—
End
—
Estimated
£100.0m
CPV
METHOTREXATE
Start
—
End
—
Estimated
£100.0m
CPV
NIVOLUMAB
Start
—
End
—
Estimated
£100.0m
CPV
OXALIPLATIN
Start
—
End
—
Estimated
£100.0m
CPV
PACLITAXEL
Start
—
End
—
Estimated
£100.0m
CPV
PEMBROLIZUMAB
Start
—
End
—
Estimated
£100.0m
CPV
PERTUZUMAB
Start
—
End
—
Estimated
£100.0m
CPV
RITUXIMAB
Start
—
End
—
Estimated
£100.0m
CPV
TRASTUZUMAB SC
Start
—
End
—
Estimated
£100.0m
CPV
TRASTUZUMAB IV
Start
—
End
—
Estimated
£100.0m
CPV
VINCRISTINE
Start
—
End
—
Estimated
£100.0m
CPV
Aseptically Prepared Dose Banded Medicines
Start
—
End
—
Estimated
£500.0m
CPV
CIVAS (Centralised Intravenous Additive Service)
Start
—
End
—
Estimated
£200.0m
CPV
Patient Specific Chemotherapy
Start
—
End
—
Estimated
£300.0m
CPV
Other contracts from HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Qualasept Ltd t/a Bath ASU· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Framework Agreement for the Provision of Dose Banded Chemotherapy Services | contract | £3.0m | 22 Jun 2026 |
| Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services | contract | — | 07 Apr 2026 |
| Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services | contract | — | 26 Jan 2026 |
| Framework for the supply of Ready to Administer Products | contract | — | 23 Oct 2025 |
| Supply of Nonchemotherapy Compounded Monoclonal Antibodies | contract | — | 06 Oct 2025 |
| Framework for the supply of Ready to Administer Products | contract | — | 22 Sept 2025 |
| D105 - Ready to Administer Products | contract | — | 20 Aug 2025 |
| Aseptically Manipulated or Terminally Sterile Medicinal Products | contract | — | 20 Aug 2024 |
| Aseptically Manipulated or Terminally Sterile Medicinal Products Framework (Lot 5) | contract | — | 20 Aug 2024 |
| Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) | contract | — | 09 Aug 2024 |